Skip to main content
OpenTrials

Clinical trial condition

Spasm

Explore clinical trials studying Spasm. Study availability and eligibility vary by location and protocol.

85 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Spasm trial results

Completed

Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years

NCT03325881

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • PEWMD, PA, ARCSM, PLLC, PRP, Inc. Little Rock, Arkansas, United States
  • Advanced Research Center Anaheim, California, United States
  • Riverside Medical Clinic Riverside, California, United States
View all 41 locations
View Trial Details
Completed

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

NCT01238575

Conditions
Asperger Syndrome, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Lexington, Massachusetts, United States
View Trial Details

Related conditions